No app helps GLP-1 users eat right. Smart meals that respect your nausea, hit your protein, and use what's in your fridge.
| Name | Domain | App Store Clear? | Trademark Risk | Notes | Score |
|---|---|---|---|---|---|
| NurseChef | Checkable | Clear | Low | Healthcare + meal planning. Communicates expertise and actionability. | 8/10 |
| ProteinSync | Checkable | Clear | Low | High-protein focus implicit. "Sync" implies integration. | 7/10 |
| NauseaGone Meals | Checkable | Clear | Medium | Literal but high ASO keyword density. May trigger FDA language concerns. | 6/10 |
| GLP Coach | Checkable | Crowded | Low | Direct keyword match. Risk of confusion with existing GLP-1 apps. | 6/10 |
.app domains rank higher in App Store and Google searches. "glp1nutrition" and "glpcoach" are both direct GLP-1 keywords with high commercial intent. Owning both blocks competitors. Available domains: glp1coach.app ($14.99/yr), glp1nutrition.app ($14.99/yr), nourashglp.com ($11.25/yr), glpcoach.app ($14.99/yr). Note: glpmeals.com is taken.
The GLP-1 Nutrition Coach addresses a critical and underserved gap in the rapidly expanding GLP-1 medication ecosystem. While several shot-tracking apps exist (Shotsy, Pep, MeAgain), no major player has successfully dominated nutrition coaching with nausea-friendly meal planning and high-protein meal design specifically engineered for GLP-1 users.
The addressable market is substantial: with GLP-1 medications approaching $80-130 billion in annual revenue globally, and an estimated 8-12 million active GLP-1 users in North America alone, even a 5% penetration would yield 400,000-600,000 potential users.
TAM: 8-12M active GLP-1 users globally at $15-25/month = $1.4-3.6B annually. SAM: English-speaking GLP-1 users in US/Canada/UK seeking nutrition coaching = 2-3M users = $360M-900M annually. SOM Year 1: With strong ASO and marketing, target 50,000-100,000 paying users = $9-30M revenue. Sources: Grand View Research, Roots Analysis, Polaris Market Research, Towards Healthcare, Business Research Insights.
Monetization model, key features, strengths, and the primary weakness for each competitor in the GLP-1 companion app space.
AI photo-based meal logging with protein/fiber tracking. Injection tracking + site rotation. Direct medication sourcing (zero-markup semaglutide/tirzepatide). Body composition analysis. Apple Health integration.
$199/month for medication. $6.67/month app (billed annually). Ranked #1 semaglutide app (Dec 2025).
Food logging can't edit portion sizes (must re-add items). No nausea-specific meal guidance. Premium pricing limits addressable market.
Free injection tracking and dose reminders. Weight, side effects, calories, protein, water logging. Site rotation tracking. Charts and trend analysis. iOS and Android parity.
Completely free with robust feature set. No monetization strategy visible (sustainability risk).
Generic nutrition tracking — not GLP-1 specialized. Users must duplicate tracking across multiple apps (Shotsy + separate food app). No AI meal planning.
Free AI meal tracking (no subscription). Photo-based meal logging. Dose reminders. Community features. Multilingual (English, Turkish, Spanish, Portuguese).
No paywall after 3 messages. Free-first model removes friction. No monetization clarity.
Basic feature set vs. MeAgain. No injection tracking integration. No personalization for nausea or high-protein needs.
Shot + pill tracking. Nutrition logging (calories, protein, fiber). AI food scanner. Customizable reminders. Injection site rotation tracking.
Requires subscription (pricing not disclosed). Free tier exists but limited. Highly responsive customer service.
Moderate user base vs. MeAgain. No medication sourcing. No nausea-specific guidance.
GLP-1 tracking with smart analytics. Drug concentration level estimation. Side effect pattern recognition. Weight loss trend analysis. Privacy-first design.
Best free app available (per reviews). No data monetization. Privacy-centric.
Limited nutrition features. Weak meal planning. No AI integration. Passive approach to nausea/appetite challenges.
No competitor integrates injection tracking + nausea-specific meal planning + protein coaching seamlessly. Users juggle Shotsy + MyFitnessPal + separate nutritionist advice. 1 in 5 GLP-1 users experience moderate-to-severe nausea (Reddit analysis of 67,000+ users), yet NO app provides nausea-triggered meal recommendations. Users must eat 80-120g protein daily to preserve muscle, but current apps track protein without providing smart meal suggestions that respect suppressed appetite. MeAgain can't edit portions. Shotsy users explicitly complain about duplicating food across apps. Food waste anxiety is rampant ("I bought food and couldn't eat it due to nausea"). Sources: Fox News Reddit Side Effects Study, WebMD, Today Show, Shotsy/MeAgain App Store reviews.
| Element | Recommended Copy | Notes |
|---|---|---|
| App Store Title | NurseChef: GLP-1 Meals | Combines brand + primary keyword |
| Subtitle | Nausea-friendly nutrition coach | Hits niche keyword + differentiator |
| Primary Category | Health & Fitness | — |
Strong product-market fit on the nutrition gap. No competitor owns nausea-aware meal engineering or fridge-to-meal AI. Market is in growth phase with no player at >50% penetration. Vertical specialization (nutrition + nausea) vs. horizontal trackers creates whitespace. Key to success: differentiate on nausea-aware meal engineering and fridge-to-meal AI workflow. Don't compete on shot tracking (Shotsy won). Don't match MeAgain's pharma model. Own nutrition expertise.
| Biggest Risk | Biggest Opportunity |
|---|---|
| Commodity feature competition: MeAgain and Pep can add nausea-aware meals in 1-2 sprints. Regulatory/medical claims risk with FDA if using "treats nausea" language. | First-mover on nausea-aware meal engineering + fridge-scanning-to-GLP1-recipes workflow. Proprietary ML model for nausea prediction could create defensible moat. $80-130B drug market with companion app ecosystem still in infancy. |
| Risk | Severity | Mitigation |
|---|---|---|
| Commodity Feature Competition | HIGH | Build proprietary ML model for nausea prediction. Patent fridge-scanning-to-GLP1-recipes workflow. Move fast to 50K users before competitors respond. |
| Regulatory/Medical Claims | HIGH | Use careful language: "Suggests meals GLP-1 users report tolerating well" (not "treats" or "prevents"). Partner with board-certified nutritionists. Review copy with healthcare legal counsel. |
| Pharma Distribution Moat | MEDIUM | Focus on nutrition expertise, not pharma. Partner with TeleHealth platforms (Amazon Pharmacy, GoodRx) for referral revenue. Position as "nutrition layer" on top of existing sourcing. |
| User Acquisition Cost | MEDIUM | Target organic (ASO + Reddit) for free-tier acquisition. Partner with GLP-1 clinic networks for in-clinic referrals. 30-day free premium trial. |
| Data Privacy & HIPAA | MEDIUM | Build HIPAA-compliant infrastructure from day 1. SOC 2 certification. Encrypt at rest and in transit. |
| Market Saturation | LOW | Market still in growth phase. No player has >50% penetration. Winner-take-most dynamics 2+ years away. |
Bundle ID and IAP product IDs must be created in App Store Connect first. Mismatches are the #1 cause of upload failures.
com.dreamseeds.nursechefRegister in Apple Developer Portal. Certificates, IDs & Profiles. Identifiers.
Free tier: basic meal tracking, 50+ nausea-friendly recipes, weekly meal prep templates, protein goal tracker. Premium: $12.99/mo or $99/yr.
Adult on semaglutide/tirzepatide struggling with nausea, low appetite, protein targets, and food waste. Needs smart meal suggestions that respect suppressed appetite.
| # | Feature | Why It Matters | Session |
|---|---|---|---|
| 1 | Nausea-Friendly Recipe Database | 200+ recipes filtered by nausea tolerance level, high-protein, micro-portion friendly. No competitor has this. | S2 |
| 2 | AI Photo Meal Logging | Camera-based meal logging with instant protein/fiber analysis. Auto-adjustable portion sizes (1.5oz, not just standard servings). | S3 |
| 3 | Nausea Prediction Engine | ML model using injection timing + meal history to predict nausea triggers and suggest safe meals proactively. | S5 |
| 4 | Fridge-to-Meal Scanner | Camera scan fridge contents. AI suggests GLP-1-friendly recipes from what's on hand. Reduces food waste. | S6 |
| 5 | Protein Goal Coaching | Smart daily protein tracker with meal suggestions to hit 80-120g target despite suppressed appetite. Fatigue-aware meal timing. | S4 |
| Year | Total Users | Paying Users | MRR | Annual Revenue |
|---|---|---|---|---|
| Year 1 (Conservative) | 50K | 15K (30%) | $180K | $2.16M |
| Year 2 (Growth) | 200K | 70K (35%) | $840K | $10.08M |
| Year 3 (Scale) | 500K | 200K (40%) | $2.4M | $28.8M |
App Store rating: 4.5+ stars (vs. competitors 4.56). Day-30 retention: 50%+ (GLP-1 apps avg 35-40%). Free-to-paid conversion: 30%+ (vs. industry 2-5%). CAC payback: less than 12 months. NPS: 60+ (premium customer loyalty). Pricing: $12.99/month ($99/year discount = $8.25/month blended). Premium tier $24.99/month for 5-10% of users. Gross Margin: 75-80% (SaaS model).